Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Gynecologic Oncology|March 26, 2005
Metachronous colorectal malignancies: "don't forget the neo vagina". A case reportArjan P Schouten van der Velden, Ignace H J T de Hingh, Charles P Schijf, et al.Annals of Surgical Oncology|November 15, 2006
Can surgical oncologists reliably predict the likelihood for non-SLN metastases in breast cancer patients?Marjolein L Smidt, Luc J A Strobbe, Hans M M Groenewoud, et al.International Journal of Radiation Oncology, Biology, Physics|June 5, 2007
Local recurrences after different treatment strategies for ductal carcinoma in situ of the breast: a population-based study in the East NetherlandsArjan P Schouten van der Velden, Roel van Vugt, Jos A A M Van Dijck, et al.World Journal of Surgery|February 28, 2002
Critical analysis of the treatment of non-palpable breast cancer: toward a less invasive future?Richard P R Groenendijk, Han ter Horst, John G M Tinnemans, et al.International Journal of Cancer|September 24, 2004
Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patientsCharlotte F J M Peeters, Johan R Westphal, Robert M W de Waal, et al.Cancer|September 3, 2009
More tumor-affected lymph nodes because of the sentinel lymph node procedure but no stage migration, because the 2002 TNM classifies small tumor deposits as pathologic N0 breast cancerMarieke J Bolster, Peter Bult, Carla A P Wauters, et al.Anticancer Research|May 4, 2005
No association between genetic polymorphisms in NAD(P)H oxidase p22phox and paraoxonase 1 and colorectal cancer riskElise M J Van Der Logt, Cynthia H J M Janssen, Zairah Van Hooijdonk, et al.Cancer|June 29, 2006
Epithelioid sarcoma: Still an only surgically curable diseaseSebastiaan A H J de Visscher, Robbert J van Ginkel, Theo Wobbes, et al.Cancer Letters|July 28, 2005
Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancerMichel F P van der Jagt, Fred C G J Sweep, Erwin T Waas, et al.Surgery|January 28, 2005
Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastasesCharlotte F J M Peeters, Lioe-Fee de Geus, Johan R Westphal, et al.Pageof 6